Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003
Published online before print March 27, 2003, doi: 10.1161/01.RES.0000069211.82346.46
A more recent version of this article appeared on April 18, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/7/725    most recent
01.RES.0000069211.82346.46v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pu, W. T.
Right arrow Articles by Izumo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pu, W. T.
Right arrow Articles by Izumo, S.

Submitted on October 28, 2002
Revised on February 27, 2003
Accepted on March 18, 2003

NFAT Transcription Factors Are Critical Survival Factors That Inhibit Cardiomyocyte Apoptosis During Phenylephrine Stimulation In Vitro

William T. Pu ; Qing Ma ; and Seigo Izumo *

From the Department of Cardiology (W.T.P.), Children's Hospital, Boston, Mass; and Division of Cardiovascular Research (Q.M., S.I.), Beth Israel Deaconess Medical Center, Boston, Mass.

* To whom correspondence should be addressed. E-mail: sizumo{at}caregroup.harvard.edu.

Biomechanical stress on the heart results in activation of numerous signaling cascades, leading to cardiomyocyte hypertrophy, apoptosis, and ultimately, heart failure. The Ca2+-dependent phosphatase calcineurin is an essential mediator of cardiac hypertrophy, and in most but not all studies, calcineurin inhibition attenuated cardiac hypertrophy in vivo. However, calcineurin inhibition has been reported to have adverse effects on cardiac remodeling and cardiomyocyte apoptosis. Calcineurin regulates the activity of a number of downstream targets, including the transcription factors NFAT, MEF2, and NF-{kappa}B, and the apoptotic factor Bad. To evaluate the contribution of NFAT activation by calcineurin to cardiomyocyte responses to hypertrophic stimulation, we used adenovirus to express VIVIT, a selective peptide inhibitor of calcineurin-mediated NFAT activation. We found that selective NFAT inhibition during phenylephrine stimulation inhibited hypertrophy but resulted in increased cardiomyocyte apoptosis. In contrast, nonselective inhibition of calcineurin by cyclosporin A did not cause cardiomyocyte apoptosis after phenylephrine stimulation. Cyclosporin A suppressed the effect of VIVIT on cardiomyocyte apoptosis. These results demonstrate that during phenylephrine stimulation calcineurin activates both pro- and antiapoptotic pathways in cardiomyocytes, and that NFAT activity is a critical component of the antiapoptotic pathway that regulates whether the outcome of calcineurin activation is cardiomyocyte apoptosis or survival.


Key words: apoptosis • cardiac hypertrophy • calcineurin • NFAT • phenylephrine




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
X. Jiang, P. F. Austin, R. A. Niederhoff, S. R. Manson, J. J. Riehm, B. L. Cook, G. Pengue, K. Chitaley, K. Nakayama, K. I. Nakayama, et al.
Mechanoregulation of Proliferation
Mol. Cell. Biol., September 15, 2009; 29(18): 5104 - 5114.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. M. MacDonnell, J. Weisser-Thomas, H. Kubo, M. Hanscome, Q. Liu, N. Jaleel, R. Berretta, X. Chen, J. H. Brown, A.-K. Sabri, et al.
CaMKII Negatively Regulates Calcineurin-NFAT Signaling in Cardiac Myocytes
Circ. Res., August 14, 2009; 105(4): 316 - 325.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Ikeda, A. He, S. W. Kong, J. Lu, R. Bejar, N. Bodyak, K.-H. Lee, Q. Ma, P. M. Kang, T. R. Golub, et al.
MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes
Mol. Cell. Biol., April 15, 2009; 29(8): 2193 - 2204.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. R.K. Kumarapeli, H. Su, W. Huang, M. Tang, H. Zheng, K. M. Horak, M. Li, and X. Wang
{alpha}B-Crystallin Suppresses Pressure Overload Cardiac Hypertrophy
Circ. Res., December 5, 2008; 103(12): 1473 - 1482.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. J. Flockhart, B. L. Diffey, P. M. Farr, J. Lloyd, and N. J. Reynolds
NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure
FASEB J, December 1, 2008; 22(12): 4218 - 4227.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bourajjaj, A.-S. Armand, P. A. da Costa Martins, B. Weijts, R. van der Nagel, S. Heeneman, X. H. Wehrens, and L. J. De Windt
NFATc2 Is a Necessary Mediator of Calcineurin-dependent Cardiac Hypertrophy and Heart Failure
J. Biol. Chem., August 8, 2008; 283(32): 22295 - 22303.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Huang, C. D. Wright, S. Kobayashi, C. L. Healy, M. Elgethun, A. Cypher, Q. Liang, and T. D. O'Connell
GATA4 is a survival factor in adult cardiac myocytes but is not required for {alpha}1A-adrenergic receptor survival signaling
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H699 - H707.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Belmont, A. Tadimalla, W. J. Chen, J. J. Martindale, D. J. Thuerauf, M. Marcinko, N. Gude, M. A. Sussman, and C. C. Glembotski
Coordination of Growth and Endoplasmic Reticulum Stress Signaling by Regulator of Calcineurin 1 (RCAN1), a Novel ATF6-inducible Gene
J. Biol. Chem., May 16, 2008; 283(20): 14012 - 14021.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
J. G. Pan and T. W. Mak
Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?
Sci. Signal., April 10, 2007; 2007(381): pe14 - pe14.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Suzuki, E. Bayna, H. L. Li, E. D. Molle, and W. Y.W. Lew
Lipopolysaccharide Activates Calcineurin in Ventricular Myocytes
J. Am. Coll. Cardiol., January 30, 2007; 49(4): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. Champattanachai, R. B. Marchase, and J. C. Chatham
Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C178 - C187.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Sun, G. Yan, A. Ren, B. You, and J. K. Liao
FHL2/SLIM3 Decreases Cardiomyocyte Survival by Inhibitory Interaction With Sphingosine Kinase-1
Circ. Res., September 1, 2006; 99(5): 468 - 476.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Heger and G. Euler
iNOS - Another cardiac target of calcineurin
Cardiovasc Res, September 1, 2006; 71(4): 612 - 614.
[Full Text] [PDF]


Home page
J. Immunol.Home page
F. Ikeda, R. Nishimura, T. Matsubara, K. Hata, S. V. Reddy, and T. Yoneda
Activation of NFAT Signal In Vivo Leads to Osteopenia Associated with Increased Osteoclastogenesis and Bone-Resorbing Activity
J. Immunol., August 15, 2006; 177(4): 2384 - 2390.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Q. Liu, B. J. Wilkins, Y. J. Lee, H. Ichijo, and J. D. Molkentin
Direct Interaction and Reciprocal Regulation between ASK1 and Calcineurin-NFAT Control Cardiomyocyte Death and Growth
Mol. Cell. Biol., May 15, 2006; 26(10): 3785 - 3797.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
Y. J. Kang
Cardiac Hypertrophy: A Risk Factor for QT-Prolongation and Cardiac Sudden Death
Toxicol Pathol, January 1, 2006; 34(1): 58 - 66.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. Peters, J. Freund, and R. L. Ochs
Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells
Mol. Cancer Ther., October 1, 2005; 4(10): 1605 - 1616.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. D. Peavy, K. B. Hubbard, A. Lau, R. B. Fields, K. Xu, C. J. Lee, T. T. Lee, K. Gernert, T. J. Murphy, and J. R. Hepler
Differential Effects of Gq{alpha}, G14{alpha}, and G15{alpha} on Vascular Smooth Muscle Cell Survival and Gene Expression Profiles
Mol. Pharmacol., June 1, 2005; 67(6): 2102 - 2114.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Mathew, E. Mascareno, and M. A. Q. Siddiqui
A Ternary Complex of Transcription Factors, Nished and NFATc4, and Co-activator p300 Bound to an Intronic Sequence, Intronic Regulatory Element, Is Pivotal for the Up-regulation of Myosin Light Chain-2v Gene in Cardiac Hypertrophy
J. Biol. Chem., September 24, 2004; 279(39): 41018 - 41027.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Fiedler and K. C Wollert
Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes
Cardiovasc Res, August 15, 2004; 63(3): 450 - 457.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. D Molkentin
Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs
Cardiovasc Res, August 15, 2004; 63(3): 467 - 475.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. P.M van Empel and L. J De Windt
Myocyte hypertrophy and apoptosis: a balancing act
Cardiovasc Res, August 15, 2004; 63(3): 487 - 499.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Kawamura, K. Ono, T. Morimoto, M. Akao, E. Iwai-Kanai, H. Wada, N. Sowa, T. Kita, and K. Hasegawa
Endothelin-1-Dependent Nuclear Factor of Activated T Lymphocyte Signaling Associates With Transcriptional Coactivator p300 in the Activation of the B Cell Leukemia-2 Promoter in Cardiac Myocytes
Circ. Res., June 11, 2004; 94(11): 1492 - 1499.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. A. Zaichuk, E. H. Shroff, R. Emmanuel, S. Filleur, T. Nelius, and O. V. Volpert
Nuclear Factor of Activated T Cells Balances Angiogenesis Activation and Inhibition
J. Exp. Med., June 7, 2004; 199(11): 1513 - 1522.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Tokudome, T. Horio, M. Fukunaga, H. Okumura, J. Hino, K. Mori, F. Yoshihara, S.-I. Suga, Y. Kawano, M. Kohno, et al.
Ventricular Nonmyocytes Inhibit Doxorubicin-Induced Myocyte Apoptosis: Involvement of Endogenous Endothelin-1 as a Paracrine Factor
Endocrinology, May 1, 2004; 145(5): 2458 - 2466.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Frey, H. A. Katus, E. N. Olson, and J. A. Hill
Hypertrophy of the Heart: A New Therapeutic Target?
Circulation, April 6, 2004; 109(13): 1580 - 1589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. B. Morris, T. M. Pham, B. Kenney, K. E. Sheppard, and E. A. Woodcock
UTP Transactivates Epidermal Growth Factor Receptors and Promotes Cardiomyocyte Hypertrophy Despite Inhibiting Transcription of the Hypertrophic Marker Gene, Atrial Natriuretic Peptide
J. Biol. Chem., March 5, 2004; 279(10): 8740 - 8746.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
O. F. Bueno, D. J. Lips, R. A. Kaiser, B. J. Wilkins, Y.-S. Dai, B. J. Glascock, R. Klevitsky, T. E. Hewett, T. R. Kimball, B. J. Aronow, et al.
Calcineurin A{beta} Gene Targeting Predisposes the Myocardium to Acute Ischemia-Induced Apoptosis and Dysfunction
Circ. Res., January 9, 2004; 94(1): 91 - 99.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. B. Vega, R. Bassel-Duby, and E. N. Olson
Control of Cardiac Growth and Function by Calcineurin Signaling
J. Biol. Chem., September 26, 2003; 278(39): 36981 - 36984.
[Full Text] [PDF]